Form 4: Amneal Pharmaceuticals Director Gautam Patel Sells 80,000 Shares

Director Gautam Patel sold 80,000 shares of Amneal Pharmaceuticals (AMRX) at an average price of $8.14 on February 3, 2025, according to a Form 4 filing.

Summary

• Gautam Patel, a director of Amneal Pharmaceuticals, sold 80,000 shares of Class A Common Stock on February 3, 2025.
• The sale was executed at a price of $8.14 per share.
• The total value of the transaction was approximately $651,200.
• Following the transaction, Patel directly owns 1,888,886 shares of Amneal Pharmaceuticals.
• The sale was conducted automatically under a pre-arranged trading plan (Rule 10b5-1(c)) adopted on August 15, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was pre-planned under Rule 10b5-1(c) and doesn't necessarily reflect a change in the director's outlook on the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding 10% or more of the company's shares) buy or sell the company's stock. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Sales by insiders don't necessarily indicate a negative outlook, as they can be motivated by personal financial planning needs.

Key Dates